研究将Ozempic和Wegovy的减重药物与严重眼病风险略微增加联系起来。 Studies link weight-loss drugs Ozempic and Wegovy to a slight increased risk of serious eye conditions.

新的研究表明,流行性减重药物,如Ozempic和Wegovy, 可能略微增加严重眼病的风险,包括非神经前代缺血性眼科神经病(NAION),这可能造成突然视力丧失。 New studies suggest that popular weight-loss drugs like Ozempic and Wegovy may slightly increase the risk of serious eye conditions, including non-arteritic anterior ischemic optic neuropathy (NAION), which can cause sudden vision loss. 这项涉及159 000多名糖尿病患者的研究发现,NAION和其他视神经疾病的风险略有增加。 The research, involving over 159,000 diabetes patients, found a modest risk increase for NAION and other optic nerve disorders. 虽然风险很小,但专家建议对使用这些药物的病人定期进行眼科检查。 While the risk is small, experts recommend regular eye check-ups for patients using these medications.